Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53,041,500
-
Number of holders
-
141
-
Total 13F shares, excl. options
-
22,440,998
-
Shares change
-
-459,321
-
Total reported value, excl. options
-
$784,589,581
-
Value change
-
-$47,809,544
-
Put/Call ratio
-
85%
-
Number of buys
-
79
-
Number of sells
-
-97
-
Price
-
$34.96
Significant Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q1 2020
196 filings reported holding CDLX - Cardlytics, Inc. - Common Stock, par value $0.0001 as of Q1 2020.
Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) has 141 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22,440,998 shares
of 53,041,500 outstanding shares and own 42% of the company stock.
Largest 10 shareholders include CAS Investment Partners, LLC (3,951,515 shares), FMR LLC (1,489,948 shares), WELLINGTON MANAGEMENT GROUP LLP (1,264,049 shares), BlackRock Inc. (1,194,371 shares), VANGUARD GROUP INC (1,071,083 shares), 683 Capital Management, LLC (866,606 shares), Grantham, Mayo, Van Otterloo & Co. LLC (808,000 shares), KPS Global Asset Management UK Ltd (750,000 shares), Antipodean Advisors LLC (656,000 shares), and JS Capital Management LLC (544,100 shares).
This table shows the top 141 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.